Valuation: Giant Biogene Holding Co., Ltd.

Capitalization 25.81B 29.73B 3.8B 3.26B 2.99B 2.82B 5.22B 367B 5.3B 35.42B 13.86B 173B 14.24B 13.94B 603B P/E ratio 2026 *
13.4x
P/E ratio 2027 * 11.7x
Enterprise value 18.29B 21.07B 2.69B 2.31B 2.12B 2B 3.7B 260B 3.76B 25.1B 9.82B 123B 10.09B 9.88B 427B EV / Sales 2026 *
2.97x
EV / Sales 2027 * 2.49x
Free-Float
43.65%
Yield 2026 *
4.24%
Yield 2027 * 4.69%
1 day+0.64%
1 week-5.12%
Current month-6.69%
1 month-11.94%
3 months-16.87%
6 months-21.11%
Current year-15.32%
1 week 27.58
Extreme 27.58
29.92
1 month 27.58
Extreme 27.58
33.36
Current year 27.2
Extreme 27.2
38
1 year 27.2
Extreme 27.2
82.05
3 years 27.2
Extreme 27.2
87.1
5 years 24.3
Extreme 24.3
87.1
10 years 24.3
Extreme 24.3
87.1
Manager TitleAgeSince
Chief Executive Officer 59 21/04/2022
Director of Finance/CFO 39 21/04/2022
Corporate Secretary 30 01/10/2018
Director TitleAgeSince
Chairman 59 21/04/2022
Director/Board Member 55 30/11/2021
Director/Board Member 67 06/10/2022
Change 5d. change 1-year change 3-years change Capi.($)
+0.64%-5.12%-65.53%-22.48% 3.8B
+0.81%+0.14%-14.01%-7.01% 332B
-0.21%+1.13%-19.29%-10.86% 125B
+0.37%+2.82%-1.78%+13.04% 72.3B
-0.05%-1.79%-6.57%-16.28% 59.12B
+0.99%+0.76%-28.22%-36.39% 33.25B
+2.71%-4.79%+18.34%-60.88% 28.29B
-0.31%+2.71%-10.20%-18.38% 18.5B
+2.01%+3.03%-40.74%-43.49% 18.3B
+0.12%+0.56%-6.10%+12.17% 16.86B
Average +0.63%-0.44%-17.41%-19.06% 70.75B
Weighted average by Cap. +0.21%+0.32%-13.13%-10.82%

Financials

2026 *2027 *
Net sales 6.15B 7.09B 905M 778M 712M 673M 1.24B 87.39B 1.26B 8.44B 3.3B 41.26B 3.4B 3.32B 144B 7B 8.07B 1.03B 885M 811M 766M 1.42B 99.46B 1.44B 9.61B 3.76B 46.95B 3.86B 3.78B 164B
Net income 1.94B 2.23B 285M 245M 224M 212M 392M 27.52B 398M 2.66B 1.04B 12.99B 1.07B 1.05B 45.24B 2.24B 2.58B 329M 283M 259M 245M 452M 31.75B 459M 3.07B 1.2B 14.99B 1.23B 1.21B 52.21B
Net Debt -7.52B -8.66B -1.11B -950M -870M -822M -1.52B -107B -1.54B -10.31B -4.04B -50.4B -4.15B -4.06B -176B -8.37B -9.63B -1.23B -1.06B -968M -915M -1.69B -119B -1.72B -11.48B -4.49B -56.08B -4.62B -4.52B -195B
Logo Giant Biogene Holding Co., Ltd.
Giant Biogene Holding Co Ltd is an investment holding company primarily engaged in the research, development, manufacture and sale of bioactive material-based beauty and health products. The Company's main products include professional skin treatment products such as functional skincare products and medical dressings, as well as functional foods and others. The Company primarily conducts its businesses in domestic market.
Employees
2,201
Date Price Change Volume
21/05/26 28.18 $ +0.64% 1,396,241
20/05/26 28.00 $ 0.00% 4,072,200
19/05/26 28.00 $ -0.50% 3,594,608
18/05/26 28.14 $ -4.02% 7,669,200
15/05/26 29.32 $ -1.28% 3,708,556
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
28.00HKD
Average target price
44.08HKD
Spread / Average Target
+57.43%

Quarterly revenue - Rate of surprise